Clinical trial Recruiting at 34 sites Interventional Ages 60 and up

Using dexmedetomidine to improve long-term survival after cancer surgery in older patients

Official title: Impact of Perioperative Dexmedetomidine on Long-term Survival in Older Patients After Cancer Surgery: a Multicenter Randomized Trial

Run by Peking University First Hospital · NCT06030804 · Data updated 2026-11-12

This study tests if giving older patients a medication called dexmedetomidine during cancer surgery can help them recover better and live longer.

More Dexmedetomidine trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment4532 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations40 sites (Hefei, Anhui and 39 other locations)
StatusRecruiting
StartedSeptember 12, 2023
Main results expectedSeptember 2027
Study endsOctober 2030
Registry record updatedOctober 30, 2026
Trial IDNCT06030804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 60 years or older scheduled for radical cancer surgery requiring general anesthesia.

Probably not a fit

Patients with severe bradycardia, certain types of cancer surgeries, or significant hepatic or renal dysfunction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of perioperative dexmedetomidine on long-term survival outcomes in older patients undergoing cancer surgery. It aims to determine whether administering dexmedetomidine during the surgical process can enhance recovery and reduce complications, thereby improving overall survival rates. The study will involve a multicenter randomized design, comparing outcomes between patients receiving dexmedetomidine and those receiving a placebo. The focus is on older patients, who are at higher risk for complications and poorer long-term survival after surgery.

Why it matters

Potential benefit: If successful, this approach could significantly improve long-term survival rates for elderly cancer patients undergoing surgery.

How similar studies have gone: Previous studies have shown that perioperative dexmedetomidine can reduce complications and improve outcomes, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Aged 60 years or older.
2. Scheduled to undergo radical surgery for cancer under general anesthesia, with an expected surgical duration of 2 hours or longer.
3. Required patient-controlled intravenous analgesia after surgery.

Exclusion criteria:

1. Inability to communicate preoperatively due to visual, auditory, verbal. or other reasons.
2. Surgery for breast cancer or intracranial tumor.
3. Preoperative severe sinus bradycardia (\<50 beats per minute), sick sinus syndrome,or second-degree or above atrioventricular block without pacemaker.
4. Severe hepatic dysfunction (Child-Pugh class C).
5. Severe renal dysfunction (requirement of renal replacement therapy before surgery).
6. Enrolled in other clinical studies.

Where it's running

  • The First Affiliated Hospital of China University of Science and Technology
    Hefei, Anhui, China
    Recruiting
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
    Hefei, Anhui, China
    Recruiting
  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Tsinghua University Yuquan Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Cancer Hospital Chinese Academy of Medical Sciences
    Beijing, Beijing Municipality, China
    Recruiting
  • The First Affiliated Hospital of Army Medical University (Southwest Hospital)
    Chongqing, Chongqing Municipality, China
    Recruiting
Show 34 more locations
  • Fujian Provincial Hospital
    Fuzhou, Fujian, China
    Recruiting
  • The First Affiliated Hospital of Fujian Medical University
    Fuzhou, Fujian, China
    Recruiting
  • Jinjiang City Hospital (Shanghai Sixth People's Hospital, Fujian Hospital)
    Jinjiang, Fujian, China
    Recruiting
  • Guangdong General Hospital
    Guangzhou, Guangdong, China
    Recruiting
  • Peking University Shenzhen Hospital
    Shenzhen, Guangdong, China
    Recruiting
  • The First Affiliated Hospital of Shenzhen University
    Shenzhen, Guangdong, China
    Recruiting
  • The Second Affiliated Hospital of Guangxi Medical University
    Nanning, Guangxi, China
    Recruiting
  • Affiliated Cancer Hospital of Guangxi Medical University
    Nanning, Guangxi, China
    Recruiting
  • The Fourth Hospital of Hebei Medical University
    Shijiazhuang, Hebei, China
    Recruiting
  • The Second Affiliated Hospital of Harbin Medical University
    Harbin, Heilongjiang, China
    Recruiting
  • Harbin Medical University Cancer Hospital
    Harbin, Heilongjiang, China
    Recruiting
  • The First Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan, China
    Recruiting
  • Henan Provincial People's Hospital
    Zhengzhou, Henan, China
    Recruiting
  • Xiangya Hospital Central South university
    Changsha, Hunan, China
    Recruiting
  • Nanjing General Hospital of Nanjing Military Region
    Nanjing, Jiangsu, China
    Recruiting
  • Affiliated Drum Tower Hospital, Medical School of Nanjing University
    Nanjing, Jiangsu, China
    Recruiting
  • The Second Affiliated Hospital of Suzhou University
    Suzhou, Jiangsu, China
    Recruiting
  • Bethune First Hospital Of Jilin University
    Changchun, Jilin, China
    Recruiting
  • People's Hospital of Ningxia Hui Autonomous Region
    Yinchuan, Ningxia, China
    Recruiting
  • Xijing Hospital, Fourth Military Medical University
    Xi'an, Shaanxi, China
    Recruiting
  • Shandong Provincial Hospital Heze Hospital
    Heze, Shandong, China
    Recruiting
  • Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting
  • Shanxi Cancer Hospital
    Taiyuan, Shanxi, China
    Recruiting
  • Shanxi Provincial People's Hospital
    Taiyuan, Shanxi, China
    Recruiting
  • Shanxi Bethune Hospital
    Taiyuan, Shanxi, China
    Recruiting
  • Shanxi Bethune Hospital
    Taiyuan, Shanxi, China
    Recruiting
  • First Affiliated Hospital of Xinjiang Medical University
    Ürümqi, Xinjiang, China
    Recruiting
  • The First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting
  • Fujian Medical University Union Hospital
    Fuzhou, Fujian, China
    Not yet recruiting
  • Zhejiang Cancer Hospital
    Zhejiang, Hangzhou, China
    Not yet recruiting
  • Tangshan Workers' Hospital
    Tangshan, Hebei, China
    Not yet recruiting
  • The First Affiliated Hospital of University of South China
    Hengyang, Hunan, China
    Not yet recruiting
  • General hospital of eastern theater command
    Nanjing, Nanjing, China
    Not yet recruiting
  • General Hospital of Ningxia Medical University
    Yinchuan, Ningxia, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.